Nimodipine
Overview
Nimodipine is a calcium channel blocker primarily used to reduce brain damage caused by a lack of oxygen brought on by bleeding from a burst blood vessel. It works by relaxing narrowed blood vessels in the brain, facilitating improved blood flow.
API suppliers (6)
Suppliers of Nimodipine evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 3 of 6 suppliers.
4 of 6 hold a GMP certificate on record in the EU or UK registers
- DASAMI LAB PRIVATE LTDIndia1 active DMF GMP on record
- Laksh Fine Chem Private LimitedIndia1 active DMF
- BIOPHORE INDIA PHARMACEUTICALS PVT LTD1 active DMF
- LUSOCHIMICA SPAItaly1 active DMF GMP on record
- Bayer Healthcare Llc GMP on record
- USV LTD GMP on record
Patent & exclusivity (US)
Per the FDA Orange Book (6 approved US products), the latest listed US patent on Nimodipine expires 16 Apr 2038. Generic API sourcing typically opens up once these lapse.
Therapeutic areas
Do you supply Nimodipine? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.